Quarterly report pursuant to Section 13 or 15(d)

Restatement of Interim Financial Information (Tables)

v3.21.1
Restatement of Interim Financial Information (Tables)
3 Months Ended
Mar. 31, 2021
Condensed Financial Information Disclosure [Abstract]  
Schedule of the restatement on each financial statement
    As Previously Reported     Adjustments     As Restated  
Balance Sheets for the three months ended March 31, 2021 (unaudited)                  
                   
Common stock subject to possible redemption:                  
Number of common stock outstanding     24,136,072       4,613,928       28,750,000  
Value of common stock subject to possible redemption   $ 241,360,720     $ 46,139,280     $ 287,500,000  
Class A Common stock excluding common stock subject to possible redemption     4,613,928       (4,613,928 )     --  
Class A Common stock value   $ 461       (461 )     --  
Additional paid-in capital   $ 16,277,478     $ (16,253,340 )   $ 24,138  
Accumulated deficit   $ (11,278,892 )   $ (29,885,479 )   $ (41,164,371 )
Total Stockholders’ Equity (Deficit)   $ 5,000,005       (46,139,280 )   $ (41,139,275 )
Basic and diluted weighted average common stock outstanding, common stock subject to possible redemption     25,098,791       1,476,894       26,575,685  
Basic and diluted weighted average common stock outstanding, Non-redeemable common stock     13,234,542       (1,476,894 )     11,757,648  
Basic and diluted net loss per common stock, Non-redeemable common stock   $ (0.73 )   $ (0.09 )   $ (0.82 )
    As Previously Reported     Adjustments     As Restated  
Statement of Cash Flows for the three months ended March 31, 2021 (unaudited)                  
                   
Non-Cash Investing and Financing Activities:                        
Change in value of common stock subject to possible redemption     (9,627,188 )     46,139,280       36,512,092